Stephens Inc Ocular Therapeutix, Inc Put Options Transaction History
Stephens Inc
- $7.43 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OCUL
# of Institutions
222Shares Held
147MCall Options Held
1.13MPut Options Held
423K-
Vr Adviser, LLC New York, NY12.8MShares$145 Million23.46% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$143 Million98.91% of portfolio
-
Deep Track Capital, LP Greenwich, CT11.9MShares$136 Million4.4% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$131 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.3MShares$117 Million1.64% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $875M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...